Skip to main content
2024 ACVIM Forum Main banner
Icon Legend
This session is not on your agenda.
This session is on your agenda. Click again to remove it.
Presentation Icons
ACVIM Resident Research Award Eligible
ACVIM Resident Research Award Eligible
Additional Fees May Be Required
Additional Fees May Be Required
By Invite Only
By Invite Only
Capturing for On Demand
Capturing for On Demand
Cardiology Research Abstract Award Eligible
Cardiology Research Abstract Award Eligible
ERC Approved Lecture for ACVIM Residency
ERC Approved Lecture for ACVIM Residency
Poster
Poster
Livestream
Livestream
One Health
One Health
Pre-Registration Required
Pre-Registration Required
Research Abstract
Research Abstract
Specialty Symposium
Specialty Symposium
ACVIM Resident Research Award Winner
ACVIM Resident Research Award Winner
Cardiology Research Abstract Award Winner
Cardiology Research Abstract Award Winner
Back
Evaluation ViewAttendees 6

Small Animal Internal Medicine

In Person Only

Feline Hepatitis-B Virus: What Do We Know So Far?

Liver Study Group Track

Saturday, June 8, 2024
10:20am – 11:20am CT
Location: MCC Auditorium 2
CE: 1.0
ERC Approved Lecture for ACVIM Residency
Disclosure(s):
Julia Beatty, BSc(hons), BVetMed, PhD, FANZCVS (feline med), GradCertEd (Higher Ed), FRCVS: No financial relationships to disclose
Presentation Description / Summary: TBD

Hepatitis-B virus is a major cause of chronic hepatitis and hepatocellular carcinoma in people. In 2018 a hepatitis-B-like virus, domestic cat hepadnavirus (DCH), was discovered in cats. DCH has a broad global footprint and the prevalence of viraemic cats varies between less than 2% and over 17% in reports published to date. The pathogenic potential of DCH is not fully understood. Evidenceso far suggests that DCH may have a role in some cases of feline hepatocellular carcinoma and chronic hepatitis. Novel immunoassays are required to progress our understanding of the natural history of DCH infection in the cat and to determine whether DCH is feline pathogen.

Learning Objectives:

  • Understand the need to further investigate DCH based on the pathogenesis of other hepadnaviruses
  • Evaluate the evidence for a pathogenic role for DCH in feline liver diseases
  • Understand the need for novel DCH testing methodologies